Myocardial T1, T2, T2* & ECV Mapping: Upcoming Technical Solutions to Practical Problems
René Michael Botnar1
1Biomedical Engineering, King's College London, London, United Kingdom

Synopsis

Despite the current success of myocardial tissue characterization with parametric mapping approaches, the accuracy and precision of T1, T2, T2* and ECV mapping can be affected by many confounding factors such as B0 and B1 inhomogeneity, respiratory and cardiac motion, heart rate variability, magnetisation transfer and other parameters. Moreover, estimation of T1, T2 and T2* is usually done by pixel-wise fitting of the MR signal to simple exponential models that may be an oversimplification of the true MR signal evolution. Here we will review the basic myocardial mapping techniques, discuss their pros and cons and potential solutions.

Abstract

Clinical research studies have demonstrated the clinical usefulness of quantitative myocardial tissue characterization (T1 and T2 relaxation time mapping) and its ability to differentiate between healthy and diseased tissues. Quantitative T1 mapping before and after contrast agent injection allows for detection of diffuse myocardial fibrosis due to changes in water content and extracellular volume (ECV) while T2 mapping is more sensitive for oedema detection (increased water content), both important biomarkers of adverse myocardial remodelling and inflammation1,2. Native T1 mapping has been shown to enable identification of patients with amyloidosis, Fabry’s disease or iron overload while T2 mapping is especially useful in patients with inflammatory heart disease3. The usefulness of T2* mapping has been demonstrated in patients with thalassemia4 while the assessment of the ECV, which can be obtained from a pre and post contrast T1 map, is particularly useful for the detection of diffuse fibrosis, protein deposition and collagen remodeling1. Despite the current success of myocardial tissue characterization with parametric mapping approaches, the accuracy and precision of T1, T2, T2*, and ECV mapping can be affected by many confounding factors such as B0 and B1 inhomogeneities, respiratory and cardiac motion, heart rate variability, magnetisation transfer and other parameters5. Moreover, estimation of T1, T2 and T2* is usually done by pixel-wise fitting of the MR signal to a simple exponential model that may be an oversimplification of the true MR signal evolution. For these reasons, a large variety of myocardial mapping techniques exist that try to address one or several of the above problems. In order to address the challenge of oversimplified exponential signal models and to obtain quantitative MR parameters simultaneously, MR fingerprinting (MRF) has been proposed. MRF performs a pseudo random image acquisition of hundreds to thousands of highly undersampled low quality images (instead of 3-10 high quality weighted images as usually performed in conventional T1 and T2 mapping) and subsequently matches the measured MR signal (also called fingerprint) to a dictionary of unique signal evolutions for specific T1 and T2 pairs generated with the Bloch equations or extended phase graphs6. In this presentation we will review the basic myocardial mapping techniques, discuss their pros and cons and subsequently discuss potential solutions such as MRF, multitasking and other approaches.

Acknowledgements

This work was supported by the following grants: (1) EPSRC EP/P032311/1, EP/P001009/1 and EP/P007619/1, (2) BHF programme grant RG/20/1/34802, (3) King’s BHF Centre for Research Excellence RE/18/2/34213 (4) Wellcome EPSRC Centre for Medical Engineering (NS/A000049/1), and (5) the Department of Health via the National Institute for Health Research (NIHR) Cardiovascular Health Technology Cooperative (HTC) and comprehensive Biomedical Research Centre awarded to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London and King’s College Hospital NHS Foundation Trust.

References

1) Haaf P et al. JCMR (2016) 18:89; 1-12

2) Ferreira V et al. J Am Coll Cardiol (2018) 72:24; 3158-3176

3) Liu et al. JCMR (2017) 19:74; 1-10

4) Kirk P et al. Circulation (2009) 120;1961-1968

5) Kellman P et al. JCMR (2014) 16:2; 1-20

6) Ma D et al. Nature (2013) 187-92

Proc. Intl. Soc. Mag. Reson. Med. 28 (2020)